FDA advisory letters on promotions up 123% in 1995: DTC advice predominates; FY 1997 budget request.
Executive Summary
FDA AD DIVISION ADVISORY LETTERS MORE THAN DOUBLED IN FY 1995, the agency reports in its fiscal 1997 budget justification document. Actions by the Division of Drug Marketing, Advertising & Communications during fiscal 1995 included the issuance of 624 advisory letters and 46 advisory conferences, FDA said. The number of advisory conferences increased 31%, the agency observed. These advance consultations "have resulted in cost avoidances for industry and the American consumer because fewer corrective actions were necessary," FDA maintained.
You may also be interested in...
Part D Discount Liability Coming Into Focus: CMS Releases Drug Cost Data
Newly released Medicare Part D data sheds light on the sales hit that branded pharmaceutical manufacturers will face when the coverage gap discount program gets under way in 2011
FDA Skin Infections Guidance Spurs Debate On Endpoint Relevance
FDA appears headed for a showdown with clinicians and the pharmaceutical industry over the proposed new clinical trial endpoints for acute bacterial skin and skin structure infections, the guidance's approach for justifying a non-inferiority margin and proposed changes in the types of patients that should be enrolled in trials
Shire Hopes To Sow Future Deals With $50M Venture Fund
Specialty drug maker Shire has quietly begun scouting deals with a brand-new $50 million venture fund, the latest of several in-house investment arms to launch with their parent company's pipelines, not profits, as the measure of their worth